NPAS2 and hepatocellular carcinoma: For example, Cry1 and Cry2 overexpression was associated with poor OS in gastric cancer and CRC [29, 32, 33]; Npas2 was frequently upregulated in hepatocellular carcinoma (HCC) and its overexpression significantly contributed to poor prognosis of HCC patients [34].